Peripheral T-cell lymphoma unspecified

7 total trials 2 recruiting MedDRA PT

Filter these 7 trials by phase, country, sponsor and more.

Open in Search →

A First-in-Human Study of KK2223 in Participants with T-cell Non-Hodgkin Lymphoma Pending

2025-522523-96-00 1 "T-cell Non-Hodgkin Lymphoma"
A Phase 2/3 study to evaluate safety and efficacy of the combination of Bel- CHOP/ Fol-COP drugs against CHOP in newly diagnosed Peripheral … Recruiting

2023-507803-76-00 10 2024-09-26 "Peripheral T-Cell Lymphoma"
Benefit of transplantation after Complete Response In Patients with T-cell lymphoma Recruiting

2022-501710-62-02 6 2023-06-07 "Peripheral T-cell lymphoma (PTCL)"
A safety study of PF-08046044/SGN-35C in adults with advanced cancers Ended

2023-505813-26-00 1 2024-09-12 "Lymphoma, Large B-Cell, Diffuse"
A safety study of PF-08046045/SGN-35T in adults with advanced cancers Ended

2022-502390-41-00 1 2024-06-20 "Enteropathy-Associated T-Cell Lymphoma"
Study of the safety, activity, and effect on the body of ASTX660 in people with advanced cancers. Ended

2024-516679-33-00 7 2017-12-01 "Advanced Solid Tumors and Lymphomas that are metastatic or u"
ROMIDEPSIN IN COMBINATION WITH CHOEP AS FIRST LINE TREATMENT BEFORE HEMATOPOIETIC STEM CELL TRANSPLANTATION IN YOUNG PATIENTS WITH NODAL PER … Ended

2024-511639-83-00 9 2014-09-01 "Anaplastic Large T-cell Lymphoma ALK negative"

Showing 1–7 of 7 trials